IC
DERM icon

Ikarian Capital’s Journey Medical DERM Stock Holding History

Ikarian Capital’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.18M Hold
251,436
– – 0.1% 109
2025
Q4 		$1.94M Buy
+251,436
New +$1.97M 0.15% 104

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ikarian Capital's DERM Position: Q1 2026 in Review

Ikarian Capital held its Journey Medical (DERM) position steady in Q1 2026 at 251,436 shares worth $1.18M. The position accounts for 0.1% of the portfolio, ranked #109.

Ikarian Capital first reported a position in DERM in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.94M in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Ikarian Capital held 251,436 shares of Journey Medical worth $1.18M as of Q1 2026.
  • Ikarian Capital left its Journey Medical share count unchanged in Q1 2026.
  • Journey Medical made up 0.1% of Ikarian Capital's portfolio in Q1 2026, its #109 holding.
  • Ikarian Capital first reported a position in Journey Medical in Q4 2025 and has held it in 2 quarters since.
  • Ikarian Capital's Journey Medical position peaked at $1.94M in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Ikarian Capital's 13F filing for Q1 2026, filed 15 May 2026.